1,503
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Risk factors of intrahepatic biloma and secondary infection after thermal ablation for malignant hepatic tumors

, , , , , , , & show all
Pages 979-984 | Received 07 May 2019, Accepted 13 Aug 2019, Published online: 23 Sep 2019

References

  • Trojan J, Zangos S, Schnitzbauer AA. Diagnostics and treatment of hepatocellular carcinoma in 2016: standards and developments. Visc Med. 2016;32:116–120.
  • Fonseca AZ. Complications of radiofrequency ablation of hepatic tumors: frequency and risk factors. WJH. 2014;6:107.
  • Lin M, Ye J, Tian W, et al. Risk factors for bile duct injury after percutaneous thermal ablation of malignant liver tumors: a retrospective case–control study. Dig Dis Sci. 2017;62:1086–1094.
  • Kondo Y, Shiina S, Tateishi R, et al. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis. Liver Int. 2011;31:197–205.
  • Wang MQ, Shao RH, Ye HY, et al. Investigation of bile duct injury after transcatheter arterial chemoembolization. Zhonghua Zhong Liu Za Zhi. 2005;27:609–612.
  • Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101.)
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. J Vasc Interv Radiol. 2014;25:1691–1705.
  • Marchal FDR, Elias D, Rauch P, et al. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver. Ann Surg. 2006;243:82–88.
  • Liu N, Gao J, Liu Y, et al. Determining a minimal safe distance to prevent thermal injury to intrahepatic bile ducts in radiofrequency ablation of the liver: a study in dogs. Int J Hyperther. 2012;28:210–217.
  • Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:1–9.
  • van Tilborg A, Scheffer HJ, de Jong MC, et al. MWA versus RFA for perivascular and peribiliary CRLM: a retrospective patient- and lesion-based analysis of two historical cohorts. Cardiovasc Intervent Radiol. 2016;39:1438–1446.
  • Fu Y, Yang W, Wu JY, et al. Intrahepatic biliary injuries associated with radiofrequency ablation of hepatic malignancies. Chin Med J. 2011;124:1957–1963.
  • Nakata Y, Haji S, Ishikawa H, et al. Two cases of hepatocellular carcinoma located adjacent to the Glisson's capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube. Surg Laparosc Endosc Percutan Tech. 2010;20:e189–e192.
  • Ohnishi T, Yasuda I, Nishigaki Y, et al. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma. J Gastroen Hepatol. 2008;23:e410–e415.
  • Garnon J, Cazzato RL, Caudrelier J, et al. Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol. 2019;42:344–357.
  • Tak WY, Lin S-M, Wang Y, et al. Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions. Clin Cancer Res. 2018;24:73–83.
  • Ren PH, Liang X, Yu Y, et al. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethanol injection: a pilot study. Int J Hyperther. 2011;27:249–254.
  • Zhang B, Guo Y, Wu K, et al. Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management. Mol Clin Oncol. 2017;6:937–943.
  • Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119–126.
  • Dhamija E, Paul SB, Gamanagatti SR, et al. Biliary complications of arterial chemoembolization of hepatocellular carcinoma. Diagn Interv Imag. 2015;96:1169–1175.
  • Chang IS, Rhim H, Kim SH, et al. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. Am J Roentgenol. 2010;195:1131–1136.
  • Akahane M, Koga H, Kato N, et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005;25:S57–S68.
  • Su X, Li N, Chen X, et al. Incidence and risk factors for liver abscess after thermal ablation of liver neoplasm. Hepat Mon. 2016;16.
  • Rhim H, Yoon KH, Lee JM, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23:123–134.
  • Elias D, Di Pietroantonio D, Gachot B, et al. Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterol Clin Biol. 2006;30:823–827.
  • de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol. 2003;181:695–700.
  • Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. Am J Roentgenol. 2005;184:1860.